Search

Modern data strategies are needed as the landscape for clinical trials changes.

With new vaccines come new challenges – and the need for new tools. Can mass spectrometry solve the problem of impurities?

Better data brings new advances in our knowledge of genetics. PacBio VP Neil Ward explains how pharmacogenomics will accelerate precision medicine.

In Britain and around the world, the investment ecosystem dominated by males needs an urgent shake up.

What does social media have to say about Eli Lilly’s insulin price reduction?

Libmeldy gene therapy is used for the first time in the UK outside of a clinical trial.

Pipelines are changing, and chemical complexity is on the rise. What can pharma manufacturers do about it?

Why 2023 is the year that antibody manufacturers should embrace CRISPR gene editing.

AI for drug discovery has enormous potential; to unlock it, we need to reset our mindset

Lawsuit from GenBioPro is the first of its kind – but other cases are likely to follow.